Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04164199 |
| Title | Study of Tislelizumab and/or Pamiparib Containing Treatments in Participants With Advanced Malignancies |
| Recruitment | Enrolling by invitation |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | BeiGene |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | TUR | POL | NZL | ITA | FRA | AUS |